Management of adverse events associated with encorafenib plus cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer (The BEACON CRC Study) Meeting Abstract


Authors: Velez, L.; Trevino, T.; Kopetz, S.; Grothey, A.; Yaeger, R.; Gollerkeri, A.; Maharry, K.; Tabernero, J.
Abstract Title: Management of adverse events associated with encorafenib plus cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer (The BEACON CRC Study)
Meeting Title: ESMO 22nd World Congress on Gastrointestinal Cancer
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 3
Meeting Dates: 2020 Jul 1-4
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-07-01
Start Page: S224
End Page: S225
Language: English
ACCESSION: WOS:000558722000410
DOI: 10.1016/j.annonc.2020.04.036
PROVIDER: wos
Notes: Meeting Abstract: SO-21 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Rona Denit Yaeger
    315 Yaeger